https://www.biopharmadive.com/news/ftc-orange-book-patent-advair-epipen-restasis/699132/
FTC challenges patents held by nine big drugmakers, citing unfair competition | BioPharma Dive
The agency claims intellectual property for emergency allergy shot EpiPen and asthma medication Advair was “improperly listed” in an FDA database.
ftc challengespatentsheldnine
https://consumer.ftc.gov/consumer-alerts/2019/11/ftc-challenges-sellers-business-model-product-claims
FTC challenges seller’s business model & product claims | Consumer Advice
Make tens of thousands of dollars a month selling wellness products. Skeptical? Here’s why you should be.
product claims consumerftc